INTRODUCTION
With their broad utility for biotechnology, their continuous menace as infectious
pathogens, and as an integral part of our bodies (intestinal flora), unicellular
organisms remain in the focus of global research. This interest has been further
stimulated by the challenge to counteract the emergence of multi-resistant microbes,
as well as by the recent advances in establishing unicellular organisms as valid
models for human diseases. It is our great pleasure to launch the inaugural issue
of
Microbial Cell (MIC), an international, open-access,
peer-reviewed journal dedicated to microbial research. MIC is committed to the
publication of articles that deal with the characterization of unicellular organisms
(or multicellular microorganisms) in their response to internal and external stimuli
and/or in the context of human health and disease. Thus, MIC covers heterogeneous
topics in diverse areas ranging from microbial and general cell biology to molecular
signaling, disease modeling and pathogen targeting. MIC’s Editorial Board counts
with world-class leaders in a wide variety of fields, including microbiology, aging,
evolution, biotechnology, ecology, biochemistry, infection biology, and human
pathophysiology. We are convinced that MIC will appeal to readers from a broad
scientific and medical background, including basic researchers, microbiologists,
clinicians, educators and - we hope - policy makers as well as to any interested
individual.
THE PAST, PRESENT AND FUTURE OF MICROBIAL RESEARCH
Over the last decades microorganisms have been catapulted to the limelight of the
most diverse scientific and medical areas and ultimately to the minds of the general
public. Overall, four main lines of interest shape the direct influence of microbes
on our lives: (i) their relevance for a plethora of infectious diseases, (ii) their
participation in symbiotic interactions (in particular in our gut microbiota), (iii)
their biotechnological applications and resulting economic impact, and (iv) their
emanating role as model organisms for human physiology and pathology.
Infection diseases were the most common causes of death prior to the emergence of
antibiotics and the general improvement of sanitation and preventive medicine. As
a
constant threat to individual health, domesticated animals, and agricultural
productivity, microbes were omnipresent in everybody’s life and had a deep impact
at
both the social and economic levels, sometimes with pandemic proportions
(cf. the periodic episodes of Black Plague or the Irish Potato
Famine). The discovery and study of infectious microbes as well as the consequent
implementation of hygienic standards and the application of antibiotic chemotherapy
thus were instrumental for the rise of average life expectancy in the
20th century, at least in the Western world. However, microorganisms
have resulted to be much more adaptive than previously suspected and have struck
back by developing resistance to antibiotics at an ever-accelerating pace.
Non-restrictive policies regulating anti-microbial chemotherapy, the resulting
inflationary use of antibiotics in patient care and animal farming, as well as the
increased mobility, have potentiated the development and spread of super-resistant
microbial strains. As a result, we are confronted with a situation, in which
microbial infections may advance to become the new old challenge for medical
research. Only in the USA, for instance, 23,000 people die every year from the
direct consequence of infections with antibiotic-resistant bacteria 1. Especially
in developing countries, the risk
of bacterial and fungal infections is often comparable to that of diseases mediated
by unicellular parasites. For instance, malaria (in 2010: approximately 219 million
cases and 660.000 deaths 2), leishmaniosis
(approximately 12 million persons currently infected worldwide with annual
casualties in the range of 20.000-30.000 3),
or trypanosomiasis (estimated 7-8 million and 30.000 cases worldwide for American
and African trypanosomiasis, respectively 4
5), all represent major
socioeconomic burdens that directly and indirectly take a heavy toll on human
life.
Beyond the threat by external microorganisms, we are exposed to and actually depend
on our resident microbial population. The gut microbiota is comprised of a broad and
dynamic repertoire of microorganisms in which bacteria predominate but Archaea and
Eukarya are also present 6. In fact, our
enteric flora can be considered as a virtual organ 7
8 in which the number of
microbial cells is approximately ten times larger than the quantity of eukaryotic
cells contained in the whole body 9, with
important ecological, metabolic and physiological implications. The genetic
variability among commensal microbial cells (the microbiome) outnumbers that of the
human genome by more than two logs 10. Also,
the metabolic activity of the intestinal microbiota significantly contributes to and
largely affects the whole-body metabolism 11.
This tight and intricate host-microbe interplay reflects a symbiotic relationship,
in which the microbial commensals contribute to the host’s energy harvesting, the
defense against infectious threats, as well as to the regulation of the immune
system 12
13. Furthermore, internal microbes directly affect inflammatory and
neoplastic disease mechanisms, condition our propensity to develop obesity and
metabolic syndrome, have a neurobehavioural impact, and influence therapeutic
responses including at the level of anticancer treatments 14
15
16
17
18
19
20
21. Importantly, most of these host-microbe
interactions remain to be deciphered in their molecular details and many microbial
populations contributing to our gut microbiome have yet to be described and
characterized. We surmise that microbial research will not only improve our
understanding of this complex ecosystem but also explore strategies for exploiting
our flora for therapeutic use.
The benefits that we derive from microbial activities reach far beyond the direct
cooperative relationship with intestinal microbes. For instance, microorganisms are
involved in maintaining the ecological flux, e.g. through recycling vital elements
like carbon and nitrogen, as elements at the base of the food chain (particularly
in
aquatic ecosystems), or as pathogens for population control. Even beyond historic
records, mankind has discovered and technically refined the employment of microbial
organisms for the production of essential food items like bread or cheese and
beverages like beer or wine. This ancient biotechnological use of microorganisms has
left a deep, millennium-long social, economic and cultural footprint. In modern
biotechnology, genetic engineering of microbes allows for the efficient
manufacturing of natural and synthetic products (including multiple drugs and
hormones), and industrial microbiology takes advantage of unicellular organisms in
large-scale processes such as wastewater treatment or industrial fermentation 22.
The evolutionary conservation of the principal biochemical and cell biological
pathways in microbes coupled to their vast technical advantages (from rapid growth
to inexpensive accessibility) has made them essential model organisms and basic
research tools to explore the fundamental processes of human physiology and
pathology. In fact, many crucial mechanisms at the foundation of human cellular
processes were first discovered in unicellular organisms, as it is the case for the
cell division cycle, elemental cell death pathways, autophagy, vesicular fusion, and
mitochondrial biogenesis 23
24
25
26
27
28
29
30
31
32
33
34
35
36. Furthermore, pathological
scenarios central to human health are successfully modeled in unicellular organisms.
For instance, it is currently estimated that half of the genes and drugs known today
to causally influence aging in multicellular animals are the result of initial
studies perfomed in yeast 37
38
39
40
41
42
43
44.
Heterologous expression of human proteins involved in different diseases are
instrumental for the causal and molecular understanding of detrimental afflictions
such as cancer and neurodegenerative disorders like Parkinson’s or Alzheimer’s
disease 45
46
47
48. Certainly, the use of unicellular organisms with the
purpose of modeling molecular mechanisms and disorders in humans demands the
subsequent validation of the results in higher eukaryotes. Nevertheless, the high
degree of conservation of basic biological processes underscores the immense
potential of microbial cells as model organisms that may well explore the
fundamental principles of human health and disease.
A UNIVERSALLY ACCESSIBLE PLATFORM FOR HIGH-QUALITY PUBLICATIONS IN THE MICROBIAL
FIELD
MIC approaches this vast thematic heterogeneity by publishing a whole array of
peer-reviewed papers, including primary research articles and reports, as well as
different formats of review and commentary articles. Given the global impact of
microbial research, MIC makes all articles freely available on the Internet to be
read, downloaded, stored, printed, copied, and distributed by any interested
individual in accordance to the journal’s commitment to the principles of
open-access publishing. This commitment reflects our conviction that science in
general and research in particular are building elements of our modern societies
that provide medical and technical improvements as well as cultural, educational and
social benefits. Being responsible for generating, conserving and diffusing this
public good, the research community needs to make full use of the World Wide Web,
for the benefit of both the scholarly and general readership. Indeed, the global
access to the Internet has fundamentally changed the way information in general and
research literature in particular can be exchanged. In contrast to print publishing
- where each transaction from the publisher to the reader involves significant cost
- online publishing allows the deposition of a single copy that can be accessed by
anyone around the world without (or with little) additional costs. Assessing
universal online accessibility to scientific knowledge allows for the quick and
unrestricted use of published data by researchers and interested individuals,
maximizes the visibility of the authors’ works, and promotes the availability of the
latest research results for educational purposes. MIC authors - who retain full
copyright of their work - must therefore agree to make their articles legally
available for reuse with no permissions required or fees raised as long as they and
the journal are appropriately cited as the original source. By pursuing an open
access approach and the universal accessibility to scientific knowledge, we support
one of the essential values of science: the free exchange of ideas.
MIC believes that the publication of a research work and the consequent dissemination
of results and thoughts among scientists and readers is a fundamental part of doing
research. Consequently, any costs generated from publication should be considered
as
one of the basic expenses to be covered by research grants or by the authors’
institutions. However, it remains a fact that due to economic restraints in
developing countries, the vast majority of biomedical publications are signed by
authors from the financially most potent nations. This also applies to the microbial
research field, even though the developing countries often suffer microbiological
threats that cost or endanger millions of lives per year. Following these concerns,
MIC has implemented a waiver program (DevResearch Program) that - depending on the
applicant’s situation - partly or completely exempts the corresponding authors based
in low-income countries from paying publication fees. The goal of this policy is to
facilitate and promote scientific authorship from developing countries. Of note,
microbial research combines both the possibility to work with affordable model
systems and direct medical applicability to microbial-derived health issues. That
is
why - by means of its DevResearch Program - MIC also intends to promote the
implementation of this research field into projects, programs and policies that may
contribute to sustainable development at the scientific and social levels.
CONCLUDING REMARKS
Altogether, it is evident that microbial research is enormously heterogeneous with
a
wide and growing impact on our lives at the academic, economic, and social levels.
MIC emerges with the intention to serve as a publishing forum that supports and
enfolds this diversity as it provides a unique, high-quality and universally
accessible source of information and inspiration. It is time to be or fall in love
with microbial research and we are convinced that you will do so through MIC - as
a
reader or a contributor.